John Finn named CSO of Basecamp

Basecamp Research Ltd. hired John Finn as CSO and Konstantinos Andrikopoulos as SVP for intellectual property, and announced the opening of a lab and office space in Boston, Mass., expanding its footprint from its home base in the U.K. Finn and Andrikopoulos join Basecamp from Tome Biosciences Inc., where they were the same roles. Basecamp, which is developing programmable genetic medicines, raised a Singular-led $60 million series B round in October to scale the dataset for its AI-based biological design platform. 

AI-based drug discovery company Iambic Therapeutics Inc. hired Michael Secora as chief corporate development officer and CFO. Secora was CFO and executive leader of value translation at Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). ...